Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v5-FR
Language French French
Date Updated 2019-03-01 2019-01-30
Drug Identification Number 02392143 02392143
Brand name BIO-AMLODIPINE BIO-AMLODIPINE
Common or Proper name AMLODIPINE AMLODIPINE
Company Name BIOMED PHARMA BIOMED PHARMA
Ingredients AMLODIPINE AMLODIPINE
Strength(s) 10.00MG 10.00MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 500
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-08-23 2018-08-23
Estimated end date 2019-01-30 2019-01-30
Actual end date 2019-02-28
Shortage status Resolved Actual shortage
Company comments
Health Canada comments